Active Ingredient(s): Sodium Phosphates
FDA Approved: * September 21, 2000
Pharm Company: * SALIX PHARMS
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Visicol Overview

Sodium phosphate is a generic term for a variety of salts of sodium (Na+) and phosphate (PO43−). Phosphate also forms families or condensed anions including di-, tri-, tetra-, and polyphosphates. Most of these salts are known in both anhydrous (water-free) and hydrated forms. The hydrates are more common than the anhydrous forms.[1] Contents 1 Uses 2 Adverse effects 3 Monophosphates 4 Di- and polyphosphates 5 References 6 External links Uses Sodium phosphates have...

Read more Visicol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Visicol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sodium Phosphates
  • Enema: 19g + 7g, 7g/118ml + 19g/118ml, 9.5g + 3.5g
  • Solution: 0.9g/5ml + 2.4g/5ml, 2.7g/15ml + 7.2g/15ml, 7.2g/15ml + 2.7g/15ml
  • Tablet: 0.398gm + 1.102gm, 1.5g
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Visicol: (1 result)

Sorted by National Drug Code
  • 65649-601 Visicol 1.5 Gm Oral Tablet by Salix Pharmaceuticals, Inc

Other drugs which contain Sodium Phosphates or a similar ingredient: (3 results)